LI
BEAT

Leap Investments’s BioTelemetry, Inc. BEAT Stock Holding History

Leap Investments’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-8,700
Closed -$419K – 563
2019
Q2 		$419K Buy
+8,700
New +$457K 0.56% 54

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Leap Investments's BEAT Position: Q3 2019 in Review

Leap Investments sold out of BioTelemetry, Inc. (BEAT) in Q3 2019, closing a stake of 8,700 shares — an estimated $419K sold.

Leap Investments first reported a position in BEAT in Q2 2019 and held it in 1 quarter. The position peaked at $419K in Q2 2019. 219 funds tracked by Wall St. Rank hold BEAT as of Q3 2019.

  • Leap Investments reported no remaining BioTelemetry, Inc. position as of Q3 2019 after selling out during the quarter.
  • Leap Investments sold 8,700 BioTelemetry, Inc. shares in Q3 2019, an estimated $419K.
  • Leap Investments first reported a position in BioTelemetry, Inc. in Q2 2019 and held it in 1 quarter.
  • Leap Investments's BioTelemetry, Inc. position peaked at $419K in Q2 2019.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2019.

Based on Leap Investments's 13F filing for Q3 2019, filed 13 Nov 2019.